Abstract

Schizophrenia is a disorder with a heterogeneous etiology involving complex interplay between genetic and environmental risk factors. The immune system is now known to play vital roles in nervous system function and pathology through regulating neuronal and glial development, synaptic plasticity, and behavior. In this regard, the immune system is positioned as a common link between the seemingly diverse genetic and environmental risk factors for schizophrenia. Synthesizing information about how the immune-brain axis is affected by multiple factors and how these factors might interact in schizophrenia is necessary to better understand the pathogenesis of this disease. Such knowledge will aid in the development of more translatable animal models that may lead to effective therapeutic interventions. Here, we provide an overview of the genetic risk factors for schizophrenia that modulate immune function. We also explore environmental factors for schizophrenia including exposure to pollution, gut dysbiosis, maternal immune activation and early-life stress, and how the consequences of these risk factors are linked to microglial function and dysfunction. We also propose that morphological and signaling deficits of the blood-brain barrier, as observed in some individuals with schizophrenia, can act as a gateway between peripheral and central nervous system inflammation, thus affecting microglia in their essential functions. Finally, we describe the diverse roles that microglia play in response to neuroinflammation and their impact on brain development and homeostasis, as well as schizophrenia pathophysiology.

Highlights

  • Schizophrenia (SCZ) is a prevalent mental illness without satisfactory treatment options

  • How could the same risk factor play a role in such opposing phenotypes? We propose that the underlying genetic background and the time of exposure are important factors that determine the effects that maternal immune activation (MIA) exerts on brain development

  • There is growing evidence from both human and animal studies that many of the risk factors for SCZ converge on their ability to promote neuroinflammation, and that these effects are mediated in part by microglia

Read more

Summary

Introduction

Schizophrenia (SCZ) is a prevalent mental illness without satisfactory treatment options. Much progress has been made in preclinical studies focusing on environmental risk factors for SCZ and other neurodevelopmental disorders (NDD) that alter brain development such as psychosocial stress, maternal immune activation (MIA), and exposure to pollution (Bergdolt and Dunaevsky, 2019; Gomes et al, 2019; Horsdal et al, 2019).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call